Overview

Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects Exposed to Cardio-pulmonary Bypass During Cardiac Surgery at High Risk of Bleeding

Phase:

Phase 2

Details

Lead Sponsor:

Cubist Pharmaceuticals LLC

Treatments:

Ecallantide
Tranexamic Acid